Challenges in designing clinical trials in cure research

by J. Eron
Published 2015-12-01

Interferons

by Lawrence J. Eron
Published 1995-01-01

Spatial epidemiology of recently acquired HIV infections across rural and urban areas of North Carolina.

by Margaret Carrel, Joseph J Eron, Michael Emch, Christopher B Hurt
Published 2014-01-01

HIV-1 populations can persist as active reservoirs in the CNS during ART treatment

by S.B. Joseph, L. Kincer, J.J. Eron, R.W. Price, R. Swanstrom
Published 2017-12-01

Th2 cytokines are associated with higher levels of intact proviruses on ART

by J. Cyktor, H. Mar, G. Laird, R. Bosch, A. Martin, J. Eron, B. Macatangay, D. Mcmahon, R. Gandhi, J. Mellors
Published 2019-12-01

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy

by J. Cyktor, R. Gandhi, R. Bosch, H. Mar, G. Laird, B. Macatangay, J. Eron, R. Siliciano, D. Mcmahon, J. Mellors
Published 2019-12-01

Does HAART efficacy translate to effectiveness? Evidence for a trial effect.

by Prema Menezes, William C Miller, David A Wohl, Adaora A Adimora, Peter A Leone, William C Miller, Joseph J Eron
Published 2011-01-01

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.

by Terra V Fatukasi, Stephen R Cole, Richard D Moore, William C Mathews, Jessie K Edwards, Joseph J Eron, CNICS investigators
Published 2017-01-01

Persistence of CD4+PD-1 high T cells despite long-term suppressive ART

by B. Macatangay, R. Gandhi, D. Mcmahon, C. Lalama, R. Bosch, J. Cyktor, C. Hensel, E. Hogg, J. Eron, J. Mellors, C. Rinaldo
Published 2017-12-01

Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.

by Pauline E Chugh, Sang-Hoon Sin, Sezgin Ozgur, David H Henry, Prema Menezes, Jack Griffith, Joseph J Eron, Blossom Damania, Dirk P Dittmer
Published 2013-01-01

Loss to clinic and five-year mortality among HIV-infected antiretroviral therapy initiators.

by Jessie K Edwards, Stephen R Cole, Daniel Westreich, Richard Moore, Christopher Mathews, Elvin Geng, Joseph J Eron, Michael J Mugavero, CNICS Research Network
Published 2014-01-01

CD8 T cells from HIV positive individuals on ART have a skewed differentiation phenotype and impaired proliferative responses

by G. Clutton, N. Goonetilleke, O. Council, Y. Xu, J. Warren, D. Lee, M.A. Fernandez, N. Archin, J. Kuruc, J. Eron, C. Gay, D. Margolis
Published 2017-12-01

Comparison of methods to quantify inducible HIV-1 outgrowth

by P. Nathan Enick, Joseph P. Brooker, Camille M. Tumiotto, Brittany T. Staines, Joseph J. Eron, Deborah K. McMahon, Rajesh T. Gandhi, John W. Mellors, Michele D. Sobolewski
Published 2021-06-01

HIV-1 Transmission linkages among persons with incident infection to inform public health surveillance

by Ann M. Dennis, Simon D.W. Frost, Kimberly Enders, Andrew E. Cressman, Erik Volz, Nicole Adams, William C. Miller, Myron S. Cohen, Victoria Mobley, Erika Samoff, Joseph J. Eron
Published 2021-07-01

HIV antibody and T cell responses on ART are associated with HIV DNA but not RNA

by S.M. Keating, B. Jones, C.M. Lalama, R. Bosch, D. McMahon, D. Hampton, E. Hogg, J. Cyktor, J.J. Eron, J.W. Mellors, M.P. Busch, R.T. Gandhi
Published 2017-12-01

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV.

by Sonia Vibhakar Patel, Dushyantha T Jayaweera, Keri N Althoff, Joseph J Eron, Janna Radtchenko, Anthony Mills, Graeme Moyle, Steven Santiago, Paul E Sax, Jason Gillman, Karam Mounzer, Richard A Elion, Gregory D Huhn
Published 2020-01-01

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study

by Gregory D. Huhn, Joseph J. Eron, Pierre-Marie Girard, Chloe Orkin, Jean-Michel Molina, Edwin DeJesus, Romana Petrovic, Donghan Luo, Erika Van Landuyt, Erkki Lathouwers, Richard E. Nettles, Kimberley Brown, Eric Y. Wong
Published 2019-08-01

Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.

by Jennifer S Lee, Stephen R Cole, Chad J Achenbach, Dirk P Dittmer, David B Richardson, William C Miller, Christopher Mathews, Keri N Althoff, Richard D Moore, Joseph J Eron, Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS)
Published 2018-01-01

24 HIV-specific, ex vivo expanded T cell therapy (HXTC) for HIV clearance: feasibility, safety and efficacy

by Julia M. Sung, JoAnnD Kuruc, Matthew Clohosey, Amanda Crooks, Shabnum Patel, Lauren Roesch, Patrick Hanley, CRussell Cruz, Nancie Archin, JosephJ Eron, Nilu Goonetilleke, Cliona M. Rooney, Catherine M. Bollard, David M. Margolis, Cynthia L. Gay
Published 2017-07-01

The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.

by Tina S Skinner-Adams, Alice S Butterworth, Kimberly A Porter, Ronald D'Amico, Fred Sawe, Doug Shaffer, Abraham Siika, Mina C Hosseinipour, Elizabeth Stringer, Judith S Currier, Tsungai Chipato, Robert Salata, Shahin Lockman, Joseph J Eron, Steven R Meshnick, James S McCarthy
Published 2012-01-01